Encompass Health (NYSE:EHC – Get Free Report) posted its earnings results on Thursday. The company reported $1.17 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12, Zacks reports. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%.
Encompass Health Trading Down 3.7 %
Shares of NYSE:EHC traded down $3.79 during midday trading on Thursday, reaching $98.41. The company’s stock had a trading volume of 1,096,302 shares, compared to its average volume of 643,975. Encompass Health has a fifty-two week low of $71.99 and a fifty-two week high of $104.55. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The firm has a 50 day moving average price of $96.43 and a two-hundred day moving average price of $95.08. The firm has a market capitalization of $9.91 billion, a price-to-earnings ratio of 23.77, a PEG ratio of 1.18 and a beta of 0.90.
Analyst Upgrades and Downgrades
EHC has been the topic of a number of research analyst reports. Truist Financial restated a “buy” rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Royal Bank of Canada boosted their price objective on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Barclays increased their target price on Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Finally, KeyCorp boosted their price target on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Nine investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $107.11.
About Encompass Health
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Featured Articles
- Five stocks we like better than Encompass Health
- Airline Stocks – Top Airline Stocks to Buy Now
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- Basic Materials Stocks Investing
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- Pros And Cons Of Monthly Dividend Stocks
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.